Delivery Order SPE2DB20D2104-SPE2DB25FMDAK
Award Date
11/27/24
Potential Completion Date
11/29/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,294.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and...
This federal contract award is for the delivery of Micardis HCT 80-12.5 mg tablet medication to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $1,425.60. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award is for the delivery of Micardis HCT 80-12.5 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,346.30 and a final completion date of December 5, 2023. It is a delivery order contract with a firm fixed price pricing type. This contract is not designated with any set-aside requirements,...
This federal contract award is for the delivery of Micardis HCT 40-12.5 mg tablet units to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 18, 2023, with a ceiling value of $2,563.80 and a completion date of September 19, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC,...
This federal contract award is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,496.52, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award is for the delivery of Micardis HCT 80-12.5 mg tablets to the Defense Logistics Agency (DLA), a major defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, on September 17, 2024 for a firm fixed price of $1,558.81. The contract has a completion date of September 18, 2024 and does not have a set-aside designation. AmerisourceBergen holds several substantial Indefinite Delivery Contracts (IDCs) with federal...
This federal contract award is for the delivery of Micardis HCT 40-12.5 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price Delivery Order with a ceiling value of $1,816.08 and an ultimate completion date of March 20, 2024. The contract was not set aside for any specific business type....
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has a ceiling value of $3,797.45 and is a firm fixed-price delivery order. It was awarded on September 17, 2021, with a completion date of September 20, 2021. The contract does not have a...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet unit doses in packages of 30, with a ceiling value of $3,822.45. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This is a delivery order contract with a firm fixed price, and the ultimate completion date is March 7, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Micardis HCT 40-12.5 mg tablets. The firm-fixed-price delivery order has a ceiling value of $2,398.33 and a completion date of December 10, 2024. The contract is not designated with a set-aside. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...